Neuralink starts study to assess brain implant’s impact on quadriplegics controlling devices by thought
Elon Musk's brain technology startup Neuralink said on Monday it has received approval to launch a new feasibility study using its brain implant and an experimental robotic arm.
Neuralink is conducting its PRIME study, aimed at evaluating the safety of its wireless brain-computer interface and surgical robot. It is assessing the initial effect of the implant in patients with quadriplegia, a form of paralysis, to control external devices with their thoughts.
The company plans to cross-enroll participants in the feasibility study from the ongoing PRIME trial, it said in a post on social media platform X.
The US Food and Drug Administration and Neuralink did not immediately respond to requests for details on the feasibility study.
Last week, the company received approval from regulator Health Canada to launch a trial of its device in Canada. Canadian neurosurgeons in partnership with the startup have regulatory approval to recruit six patients with paralysis in the study.
In the United States, Neuralink has already implanted the device in two patients. It has allowed the first patient to play video games, browse the internet, post on social media and move a cursor on his laptop.
The company has said its device is working well in the second trial patient, who has been using it to play video games and learn how to design 3D objects.
New default prompts are grouped into thematic categories to cover range of possible user interests and needs
Ai-Da's artwork is the first by a humanoid robot to be sold at auction, fetching over $1 million
If picked up by ChatGPT’s 500m weekly users, OpenAI’s browser could pose a serious threat to a core stream of...
Yaccarino says it is her decision, though Musk has a history of dismissing deputies suddenly
Change is expected to impact how 170m US users access global content, how non-US creators make money on the platform
Newly found fossils 209m years old and include at least 16 vertebrate species, seven of them previously unknown